← Open Payments lookup

RENISSE TRECIA TRILLANA: Open Payments

NPI 1073978359 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,098 in 66 payments from 12 companies in 2025. Trend: 2023 $567 · 2024 $562 · 2025 $2,098

Food & beverage: $1,999Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.12$730
Madrigal Pharmaceuticals9$404
ABBVIE INC.14$283
Takeda Pharmaceuticals U.S.A., Inc.7$195
PFIZER INC.10$156
Celltrion USA Inc.4$84
Ardelyx, Inc.2$55
Aimmune Therapeutics, Inc.2$52
Regeneron Healthcare Solutions, Inc.2$51
GENZYME CORPORATION2$48

Products named: TREMFYA, REZDIFFRA, ENTYVIO, RINVOQ, XELJANZ, DUPIXENT, VEGZELMA, IBSRELA.

Industry payments across CO — which companies pay providers there.